Oriflame targets India at 25% of global revenue by 2030
The beauty direct seller plans to deepen its tier-2 and tier-3 presence across 500 more cities, scale its India network from 2.5 lakh to at least 10 lakh beauty entrepreneurs, and shift manufacturing to Akums Drugs and Pharmaceuticals.
What happened
Oriflame plans to accelerate India growth, targeting a rise in India’s global revenue contribution to 25% by 2030. It aims to expand its direct-selling network
Key facts
- India contributed slightly less than 10% of Oriflame global revenue in 2025
- India revenue contribution target: 25% by 2030
- 2.5 lakh direct-selling brand partners
- Target: at least 10 lakh beauty entrepreneurs
- Expansion focus: next 500 cities
What changed
Oriflame plans to accelerate India growth, targeting a rise in India’s global revenue contribution to 25% by 2030. It aims to expand its direct-selling network to 10 lakh entrepreneurs, deepen tier-2/3 reach, and outsource manufacturing to Akums.
Why this matters
Targeting India for 25% of global revenue by 2030 from under 10% in 2025 signals a high-growth bet, but execution risk is elevated given the need to quadruple its beauty-entrepreneur base.
What to watch
- Quarterly India revenue growth versus global revenue growth and progress from under 10% toward the 25% mix target.
- Registered versus active beauty entrepreneur count, sales per active entrepreneur and attrition after the first 90-180 days.
- Evidence that Akums production has begun at scale, including local SKU launches, product availability and gross-margin changes.
- Number of new cities activated, city-level order frequency and repeat purchase rates in tier-2 and tier-3 markets.
- Changes in Indian direct-selling regulation, consumer-protection enforcement or scrutiny of distributor compensation plans.